Clinical characteristics of patients with drug hypersensitivity in Norway: A single-centre study

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 5, 2011, Pages 506-513

  Chalabianloo, Fatemeh ^a   Berstad, Aud ^a   Schjøtt, Jan ^a,b   Riedel, Bettina ^a,b   Irgens, Ågot ^a   Florvaag, Erik ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Adverse drug reactions; Clinical characteristics; Drug hypersensitivity; Single centre study

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CHILD; CLINICAL ASSESSMENT; DIAGNOSTIC APPROACH ROUTE; DRUG HYPERSENSITIVITY; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; NORWAY; OUTPATIENT; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN MANIFESTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DRUG HYPERSENSITIVITY; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NORWAY; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; SKIN TESTS; YOUNG ADULT;

EID: 79955142000     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2134     Document Type: Article

References (35)

1. Demoly P, Viola M, Gomes ER, Romano A. Epidemiology and causes of drug hypersensitivity. In Drug Hypersensitivity, Pichler WJ (ed.). Karger: Basel, 2007; pp. 2-17.
2. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5(4): 309-316.
3. Rawlins MD, Thomas SHL. Mechanisms of adverse drug reactions. In Textbook of Adverse Drug Reactions, (5th edn), Davies DM, Ferner RE, de Glanville H (eds.). Lippincott-Raven Publishers: London, 1998; p. 40.
4. Greenberger PA. Drug allergy. J Allergy Clin Immunol 2006; 117(2 Suppl Mini-Primer): 464-470.
5. Demoly P. Drug allergies-unknown dangers to patients. Expert Opin Drug Saf 2008; 7(4): 347-350.
6. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
7. Schnyder B. Approach to the patient with drug allergy. Immunol Allergy Clin North Am 2009; 29(3): 405-418. Review.
8. Harboe T, Johansson SG, Florvaag E, Oman H. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 2007; 62(12): 1445-1450.
9. Harboe T, Guttormsen AB, Irgens Å, Dybendal T, Florvaag E. Anaphylaxis during anaesthesia in Norway. A six-year single centre study. Anesthesiology 2005; 102: 897-903.
10. Bousquet PJ, Demoly P, Romano A, et al. Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy 2009; 64(2): 194-203.
11. Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57(1): 45-51.
12. Skov PS, Norn S, Weeke B. A new method for detecting histamine release. Agents Actions 1985; 14: 414-416.
13. Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology services: Alergológica-2005. J Investig Allergol Clin Immunol 2009; 19(Suppl 2): 45-50.
14. Barranco P, Lopez-Serrano MC. General and epidemiological aspects of allergic drug reactions. Clin Exp Allergy 1998; 28(Suppl 4): 61-62.
15. Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol 1998; 80: 185-188.
16. Gomes E, Cardoso MF, Praça F, et al. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004; 34: 1597-1601.
17. Naldi L, Conforti A, Venegani M, et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839-846.
18. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1: 305-310.
19. Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003; 90: 342-347.
20. Haddi E, Charpin D, Tafforeau M, et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236-239.
21. Ponvert C, Le Clainche L, de Blic J, et al. Allergy to beta-lactam antibiotics in children. Pediatrics 1999; 104: 45.
22. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84(1): 101-106.
23. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996; 51: 16-23.
24. Choi IS, Han ER, Lim SW, et al. Beta-lactam antibiotic sensitization and its relationship to allergic diseases in tertiary hospital nurses. Allergy Asthma Immunol Res 2010; 2(2): 114-122.
25. Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol 2008; 53(1): 2-8.
26. Zuberbier T. Urticaria. Allergy 2003; 58: 1224-1234. Review.
27. Campos-Fernández Mdel M, Ponce-De-León-Rosales S, Archer-Dubon C. Incidence and risk factors for cutaneous adverse drug reactions in an intensive care unit. Rev Invest Clin 2005; 57(6): 770-774.
28. Fiszenson-Albala F, Auzerie V, Mahe E, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149(5): 1018-1022.
29. Schubert B, Grosse Perdekamp MT, Pfeuffer P. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality? Eur J Dermatol 2005; 15(3): 164-167.
30. Roll A, Wüthrich B, Schmid-Grendelmeier P, Hofbauer G, Ballmer-Weber BK. Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs. Swiss Med Wkly 2006; 136(43-44): 684-690.
31. Kyrmizakis DE, Papadakis CE, Liolios AD, et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg 2004; 130(12): 1416-1419.
32. Van der Klauw MM, Stricker BH, Herings RM, et al. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35(4): 400-408.
33. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
34. Demoly P, Bousquet J. Drug allergy diagnosis work up. Allergy 2002; 57(Suppl 72): 37-40.
35. Messaad D, Sahla H, Benahmed S, et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.